Routine HIV testing in zoster eye disease.
Bakr Ahmed A, Hakim Navid N, Hine Paul P, Menassa Nardine N et al.
GSK · 疫苗 · 疫苗
MMR + varicella zoster vaccine 是一种疫苗,由GSK研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection、Subcutaneous Injection。
| 商品名 | MMRV zoster vaccine |
| 公司 | GSK |
| 药物类别 | 疫苗, 大分子 |
| 给药途径 | Injectable (Others), Intramuscular (IM) Injection, Subcutaneous Injection |
| 状态 | Approved |
MMR + varicella zoster vaccine 针对 3 个适应症,涉及 1 个治疗领域。
| 治疗领域 | 疾病/病症 | 分期 |
|---|---|---|
| Infections and infestations | Salmonellosis | ✓ Approved |
| Infections and infestations | Measles | ✓ Approved |
| Infections and infestations | Varicella zoster virus infection | ✓ Approved |
Bakr Ahmed A, Hakim Navid N, Hine Paul P, Menassa Nardine N et al.
Dimashkieh Chehab Nada N
Low vaccine acceptance constitutes a major obstacle for achieving herd immunity against coronavirus disease 2019 (COVID-19). Data on COVID-19 show a significant rise in the number of cumulative cases in Arab countries where vaccine uptake is lower than the uptake at the global level for the 2021-2022 period. The aim of this study is to analyze sentiments related to vaccine acceptance before and after the emergence of the COVID-19 Omicron variant in the Arab-speaking world. Tweets were collected before and after the Omicron emergence period in the Arab-speaking world using Python-enabled CAMeL Tools (Arabic Natural Language Processing toolkit) libraries. A sentiment analysis on COVID-19 vaccines using Arabic hashtags and a sentiment analysis by city were conducted. Two data sets pre-Omicron and post-Omicron tweets exhibited a difference in sentiments marking a shift towards less negativity and more neutrality. Sentiments by city showed most tweets in both periods coming from Riyadh and Jeddah in Saudi-Arabia, and from Salt in Jordan. Despite the limitations of the study, the change in sentiments detected by the study may suggest more vaccine acceptance which raises some hope and perhaps a higher vaccine uptake in the future. The sentiments by city findings may help in the design of future research.
Sun Yufang Y, Xie Ying Y, Liu Lian L, Yang Huijie H et al.
Respiratory syncytial virus (RSV) is a primary pathogen responsible for lower respiratory tract infections in both infants and the elderly. However, vaccine development has been consistently hampered by the risk of vaccine-enhanced disease (VED), while the role of the RSV attachment (G) glycoprotein has long been overlooked. Using an mRNA vaccine platform, this study systematically evaluated the roles of two critical RSV G protein domains-the central conserved domain (CCD) and the mucin-like domains-in mediating immune protection and VED. Results indicate that the mucin-like domains confer no protection and induce marked VED. Surprisingly, although CCD immunization elicits potent humoral immunity and significantly reduces viral load, it also induces Th2-biased responses and exacerbates pulmonary inflammation following RSV challenge. However, fusion of CCD with the receptor-binding domain (RBD) of SARS-CoV-2 in an mRNA vaccine (CCD + RBD) successfully redirected the Th2-biased immune responses toward a balanced Th1/Th2 profile, while significantly attenuating CCD-induced immunopathology. CD8⁺ T-cell depletion and adoptive-transfer experiments further supported a contribution of RBD-responsive CD8⁺ T cells to the reduction in pathology. These findings provide proof of concept that heterologous antigen fusion can reshape CCD-associated immunopathology in a BALB/c RSV challenge model.
Laham-Karam N N, Mäkinen P P, Koivulehto E E, Gurzeler E E et al.
Coronavirus disease 2019 (COVID-19) continues to cause outbreaks around the world despite the vast COVID-19 vaccination programs. Thus, it is important to continue developing better vaccines to protect vulnerable populations. Here, we studied the efficacy, safety, persistence and biodistribution of an adenovirus-based COVID-19 vaccine delivered intranasally. Our results confirmed that mucosal delivery leads to effective protection against infection in hamsters. A comparative study of different adenoviral vectors demonstrated that specifically Ad5-S-3M, expressing the SARS-CoV-2 spike glycoprotein ectodomain with inclusion of three common receptor binding domain mutations, induced a robust humoral immune response and effectively protected hamsters from SARS-CoV-2 infection. In addition, longitudinal analysis of vaccinated hamsters' tissues demonstrated durable vaccine transgene expression and persistent vector DNA in the nasal turbinates. This persistence may be beneficial in increasing the duration of immunity. Expression of the S-3M did not cause any aberrant changes in the hamster tissues and resulted in very few changes in cellular mRNA expression in target tissues. Safety and biodistribution assessment demonstrated restricted non-target tissue distribution of intranasally delivered vector and no significant changes in clinical blood chemistry, underlining the safety of the vaccine. These results further support that intranasal delivery is a promising approach for mucosal vaccine administration against respiratory infection pathogens and extend our knowledge of Adeno-vector persistence.
Yuan Andy Ye AY, Atanasov Vladimir V, Weston Benjamin W BW, Whittle Jeff J et al.
Racial and ethnic disparities in maternal mortality are well known, especially the higher rates for Black and Native American women. However, the underlying causes remain unclear. These disparities may stem from disparities in background health across groups or from factors specific to childbirth and maternal care. We examine maternal mortality disparities using a novel method that controls for population differences in overall health. Unadjusted maternal mortality rate (MMR) ratios for Black, Asian, Hispanic, and Native American women relative to White women, measured over 2010-2022, excluding COVID-19 deaths, are 2.7, 0.91, 0.88, and 2.58. In contrast, adjusted ratios are 1.83, 1.31, 1.27, and 1.24, respectively. Poor background health contributes to the high maternal mortality risk among Black and Native American women, while better underlying health among Asian and Hispanic women masks their elevated adjusted maternal mortality risk. We also document substantial cross-state heterogeneity in adjusted MMRs and racial/ethnic disparities in these rates. In some states, minority women face substantially higher maternal mortality risks relative to White women, while in others-notably California-health-adjusted disparities are small.
Portela Catani João Paulo JP, Smet Anouk A, Ysenbaert Tine T, Amelinck Laura L et al.
Neuraminidase (NA) is an underutilized influenza vaccine antigen despite its recognized contribution to protective immunity. Here, we compared the immunogenicity and protective potential of multiple NA antigens delivered as an adjuvanted recombinant tetrameric protein or as mRNA-LNP encoding full-length NA in naïve mice. Both vaccine types induced robust neuraminidase-inhibiting (NAI) antibody responses and conferred protection to mice challenged with antigenically homologous influenza A or B viruses. However, only immunization with NA-encoding mRNA-LNP protected against challenge with a heterologous HxN2 virus, whereas immunization with recombinant NA was associated with earlier onset of weight loss following heterologous HxN2 virus challenge. Passive transfer of immune serum revealed that protection induced by mRNA immunization can be transferred by serum, and that early onset of weight loss is not induced by recombinant NA-derived sera; on the contrary, partial protection is achieved. Finally, NAI assays against a panel of antigenically distinct HxN2 viruses showed similar breadth of inhibition.
注册免费账户还可查看另外 9996 篇文献
免费注册查看全部文献 →